Baxter International, Inc. http://www.alacrastore.com/company-snapshot/Baxter_International_Inc-1001885 Saturday, July 05, 2008 9:12:07 PM 1001885 Baxter International, Inc. en AlacraStore RSS Builder 1.0 30 US - Bioniche Pharma, a unit of Bioniche Life Sciences Inc of the Ireland acquired certain assets of the Enlon product line, from Baxter Healthcare Corp, a unit of Baxter International Inc, manufacturer and wholesaler of injectable pharmaceuticals.7/4/2008 11:07:33 AM09017M07190L09063P071813Bioniche PharmaBaxter Healthcare Corp-ENLON Product Line Certain AssetsBioniche Life Sciences IncBaxter International Inchttp://www.alacrastore.com/storecontent/Thomson_M%26A/Bioniche_Pharma_acquires_Baxter_Healthcare_Corp_ENLON_from_Baxter_International_Inc-1993067020sdc/19930670201993067020Copyright © 2008, Thomson Financial, All Rights ReservedDrugsIreland-RepPharmaceutical preparations2834FFForeignSubsidiary2834:Pharmaceutical preparations2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances5122:Drugs, drug proprietaries, and druggists' sundriesDrugsUnited StatesPharmaceutical preparations2834ILIllinoisSubsidiary941871001Mnfr,whl biopharmaceuticalsMnfr,whl biological prodUnspecifiedAssets1026884001Jul 4 20080.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.00000Bioniche Pharma, located in CoGalway, Ireland, manufacturesand wholesales sterileinjectable pharmaceuticals,vials, ampules and pre-filledsyringes. The company was wasfounded in 2000.Bioniche Pharma, located in Co Galway, Ireland, manufacturesand wholesales sterile injectable pharmaceuticals, vials,ampules and pre-filled syringes. The company was was foundedin 2000.Bioniche Pharma, located in Co Galway, Ireland, manufactures and wholesales sterile injectable pharmaceuticals, vials, ampules and pre-filled syringes. The company was was founded in 2000.1.000002.000003.000004.000005.000006.000007.00000ENLON Product Line CertainAssets of Baxter HealthcareCorp located in Illinois, US,manufactures and wholesalesinjectable pharmaceuticalslike edrophonium chloride, USPand atropine sulfate.ENLON Product Line Certain Assets of Baxter Healthcare Corplocated in Illinois, US, manufactures and wholesalesinjectable pharmaceuticals like edrophonium chloride, USPand atropine sulfate.ENLON Product Line Certain Assets of Baxter Healthcare Corp located in Illinois, US, manufactures and wholesales injectable pharmaceuticals like edrophonium chloride, USP and atropine sulfate.0.000000.000000.000000.00000Y02 Jul 08Wed, 02 Jul 2008 00:00:00 ESTDate Announced: 07/02/200802 Jul 08Date Effective: 07/02/200802 Jul 08Acq. of AssetsFriendly0.000000.000000.000000.000000.000000.00000Price/Share0.0000000.000000.0000000.00000100.00000100.000000.000000.000000.0000000.00000N0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000100.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.00000US - Bioniche Pharma, a unitof Bioniche Life Sciences Incof the Ireland acquiredcertain assets of the Enlonproduct line, from BaxterHealthcare Corp, a unit ofBaxter International Inc,manufacturer and wholesaler ofinjectable pharmaceuticals.US - Bioniche Pharma, a unit of Bioniche Life Sciences Inc of the Ireland acquired certain assets of the Enlon product line, from Baxter Healthcare Corp, a unit of Baxter International Inc, manufacturer and wholesaler of injectable pharmaceuticals.US - Bioniche Pharma, a unit of Bioniche Life Sciences Inc of the Ireland acquired certainassets of the Enlon product line, from Baxter Healthcare Corp, a unit of BaxterInternational Inc, manufacturer and wholesaler of injectable pharmaceuticals.US - Bioniche Pharma, a unit of Bioniche Life Sciences Inc of the Ireland acquired certain assets of the Enlon product line, from Baxter Healthcare Corp, a unit of Baxter International Inc,manufacturer and wholesaler of injectable pharmaceuticals.US - Bioniche Pharma, a unit of Bioniche Life Sciences Inc of the Ireland acquired certain assets of the Enlon product line, from BaxterHealthcare Corp, a unit of Baxter International Inc, manufacturer and wholesaler of injectable pharmaceuticals.Completed0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Completed-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002834:Pharmaceutical preparations249429003TorontoCanada2834ForeignPublicBNC2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances3841:Surgical and medical instruments and apparatus5047:Medical, dental, and hospital equipment & supplies5122:Drugs, drug proprietaries, and druggists' sundries673003New YorkUnited States3841IllinoisPublicBAX0.000000.000000.000000.00000Deal InformationThomson Financial Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/newstex/BW-0001-26166746newstex/BW-0001-26166746xml Jun. ##, #### (Business Wire) -- Baxter International (NYSE: BAX) will host a quarterly conference call to discuss its second quarter #### financial results on Thursday, July ##, ####, at #:## a.m. Eastern Time (#:## a.m. Central Time)....040000000401600004016048040160186/23/2008 9:10:06 AM180000001800800018004000Business WireBW-0001-26166746BAXTER INTERNATIONAL INCBAXBXTRRNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1875970ccbn/T1875970norm... - William Blair - AnalystThank you all for coming during the lunch hour. I'm sure we'll have some more stragglers coming through. I'm Ben Andrew, the Medical Technology Analyst with William Blair and am pleased to have you join us for the presentation by Baxter this morning. Rob Davis, the Company's Chief Financial Officer, will be presenting and Mary Kay Ladone is here with us as well on the podium. The breakout will be I think in the same room or a different room. But let me check that real quick -- it's actually in the Bellevue downstairs. So please join us there afterwards. Baxter is a stock that I upgraded about six weeks ago following another good quarter from the Company and I think it's the kind of name in this economic environment where people can know very clearly what they're going to get from the Company in terms of top- and bottom-line growth and feel good that they're positioned extremely well to deliver increased operating leverage over the next several years as they have... 6/19/2008 4:10:00 PMBaxter International Inc.54.0000FinalBaxter International Inc. at William Blair & Company Growth Stock Conference TranscriptBAX1:30pm ETTranscriptT1875970Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1868224ccbn/T1868224norm...The next presentation is by Baxter. We are pleased to have with us Rob Davis, the Chief Financial Officer, and Mary Kay Ladone, the Vice President of Investor Relations. Baxter is in the midst of continued very strong financial performance. The questions that we consistently get are, "When is it going to end?" so Rob and Mary Kay are going to be here to shed some light on why they continue to believe that the profitability improvements are sustainable at the Company, as well as we'd also like to touch on, I think, some of the new opportunities at the Company going forward, and not just dwell on plasma and margins. So with that Rob, why don't I turn it over to you and we'll leave plenty of time for Q&A. ... 6/11/2008 8:09:00 PMBaxter International Inc.54.0000FinalBaxter International Inc. at Goldman Sachs Healthcare Conference TranscriptBAX11:40am ETTranscriptT1868224Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/spcred/653176spcred/653176normThe latest Summary from S&Pglobalstructured6/10/2008 1:09:52 PM175Summary653176United StatesHealth Care EquipmentAsiaEmerging MarketsEurope, Middle East, AfricaLatin AmericaUnited StatesGlobal IssuersStructured FinanceCorporationsCollateralized Debt ObligationsHealth CareSummaryThe rating on Deerfield, Ill.-based Baxter International Inc. reflects its strength as a leading manufacturer of diversified and relatively noncyclical medical products. The company generates strong recurring revenues from consumables and disposables. It has sustained its business profile with extensive worldwide operations, solid distribution channels, a very large and entrenched customer base, and low-cost manufacturing. These strengths mitigate the risks of participation in an industry that is intensely competitive and faces relatively fast innovation cycles for certain products. The company has materially strengthened its balance sheet and cash generation over the past few years. Baxter develops, manufactures, and distributes products for medication delivery (about 38% of sales), bioscience applications (42%), and dialysis treatment (20%). It commits about 6% of salesUSA07181C07181D07181F07181A07181B07181E07181307181235101010 351010 3510 35Baxter International Inc.110160ASIAEMERGINGEUROMIDAFRLATAMERICAUSABAXSUMMARYGLOBISSSTRUCCORPCDOHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/ccbn/T1853903ccbn/T1853903norm...(AUDIO ALREADY IN PROGRESS) -- and I actually think is ever more becoming a key distinguisher of us is the fact that we are truly a global diversified healthcare company. And this not only allows us the ability to mitigate risk, but really to drive competitive advantage through our ability to leverage synergies whether they be operational, financial, strategic across the three businesses we operate in which, as you can see here, is BioScience, medication delivery and renal. But also, if you look at the fact that we have over ##% of our products with market leading positions and, as the slide points out, greater than ##% of our sales actually come from outside the United States. We are very well positioned with our products to take advantage of really what we're seeing, which is a real growth in both the emerging and developing markets, and a real focus towards driving towards more spend per GDP on healthcare which is really a key strategic growth driver of the Company we've talked about... 5/22/2008 12:12:00 PMBaxter International Inc.54.0000FinalBaxter International Inc. at Citigroup Healthcare Conference TranscriptBAX10:00am ETTranscriptT1853903Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/moodys/PR_155711_95000moodys/PR_155711_95000htmlGlobal Credit Research Rating Action ## MAY #### Rating Action: Baxter International Inc. Moody's assigns A# rating to Baxter's new senior notes New $### million offering New York, May ##, #### -- Moody's Investors Service assigned...5/20/2008 12:59:37 AMhtmlBaxter International Inc.Baxter Finco, B.V.Baxter Finco, B.V.; Baxter International Inc.95000808772925150.0000NewsRating ActionPR_155711_95000Credit & Investment ResearchMoody's Global Credit Researchhttp://www.alacrastore.com/storecontent/fitch/420904_pr_framefitch/420904_pr_framehtmlFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Baxter International, Inc.800910135/19/2008 2:06:00 PM010300000103170085Press ReleaseBAX420904_pr_frameCredit & Investment ResearchFitchResearchhttp://www.alacrastore.com/storecontent/spcred/649001spcred/649001normThe latest News from S&Pglobalstructured5/19/2008 1:18:44 PM100News649001United StatesHealth Care EquipmentAsiaEmerging MarketsEurope, Middle East, AfricaLatin AmericaUnited StatesGlobal IssuersStructured FinanceCorporationsCollateralized Debt ObligationsHealth CareNewsNEW YORK (Standard&Poor's) May 19, 2008--Standard&Poor's Ratings Services said today it assigned its 'A+' rating on Deerfield, Ill.-based Baxter International Inc.'s $500 million senior unsecured notes due in 2018. The company will use the proceeds for general corporate purposes, which may include the repayment of outstanding indebtedness and the refinancing of certain net investment hedges. As such, we do not expect a material, if any, increase in adjusted debt. The rating on Baxter (A+/Stable/A-1) reflects the company's strength as a leading manufacturer of diversified and relatively noncyclical medical products. The company generates strong recurring revenues from consumables and disposables. It has sustained its business profile with extensive worldwide operations, solid distribution channels, a very large andUSA07181C07181D07181F07181A07181B07181E07181307181235101010 351010 3510 35Baxter International Inc.110160ASIAEMERGINGEUROMIDAFRLATAMERICAUSABAXNEWSGLOBISSSTRUCCORPCDOHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-25238454newstex/PRN-0005-25238454xml BLOOMFIELD HILLS, Mich., May ##, May ##, #### (PR Newswire delivered by Newstex) -- BLOOMFIELD HILLS, Mich., May ## /PRNewswire/ -- CJPS Enterprises, LLC (www.CJPS-Enterprises.com) announced today that it will be holding a half-day...1100000011016000110160010200000002002000020020080200200604000000040060000400600504016000040160275/13/2008 3:07:09 PM180000001801800018014000190000001900100019001022PR Newswire USPRN-0005-25238454BAXTER INTERNATIONAL INCDELPHI CORPORATIONBAXBXTRRDLPIVDPHIQNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1838911ccbn/T1838911norm... - Baxter International - CEO, Chairman Good morning, good morning, we will now to come to order for the #### Annual Meeting of the Shareholders of Baxter International. Great crowd this morning. My name is Bob Parkinson. I am Chief Executive Officer and Chairman of the Board of Baxter International. I am pleased to be here today and I want to welcome all of you to our #### annual meeting. Later this morning, after we get through a number of the procedural elements of the program, I look forward to sharing with you some of my perspectives on Baxter, the progress that we've made and our direction for the future. Before I move onto today's business, however, I would like to add that today's meeting is being webcast and is accessible from a link on our website at www.baxter.com. When you arrived today, each of you, I hope anyway, received an agenda for the meeting, which indicates the matters that are to be considered here today. And at the conclusion of the meting, as is our practice, we... 5/7/2008 2:13:00 PMBaxter International Inc.54.0000FinalBaxter International Inc. Shareholders Meeting TranscriptBAX11:30am ETTranscriptT1838911Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1816749ccbn/T1816749norm... - Morgan Stanley - AnalystAll right, let's get started. For those of you on the webcast, this is Glenn Reicin for Morgan Stanley. With me is management from Baxter, specifically Rob Davis, CFO and Mary Kay Ladone, Vice President of Investor Relations. We have a lot of ground to cover. Why don't we sort of start of maybe and give us a little bit of a report card after the first quarter how things are shaping up so far this year relative to your plan, what you're happy about, what you are not pleased about and we will go from there. ... 5/2/2008 10:14:00 AMBaxter International Inc.54.0000FinalBaxter International Inc. at Morgan Stanley 2008 Global Healthcare Unplugged Conference TranscriptBAX10:40am ETTranscriptT1816749Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-24713049newstex/BW-0001-24713049xml CHICAGO, Apr. ##, #### (Business Wire) -- Zacks Equity Research highlights China Mobile (NYSE: CHL) as the Bull of the Day and Amylin Pharmaceuticals (Nasdaq: AMLN) as the Bear of the Day. In addition, Zacks Equity Research provides...040000000401600004016001040160480401600904002000040020064/23/2008 7:07:34 AM180000001800800018004000180110001900000019002000190020041900200919002013Business WireBW-0001-24713049AMYLIN PHARMACEUTICALS INCBAXTER INTERNATIONAL INCCASTLE BRANDSAMLNBAXBXTRRROXNewsNewstexhttp://www.alacrastore.com/storecontent/fitch/417836_pr_framefitch/417836_pr_framehtmlFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Abbott LaboratoriesAlcon Inc.AmerisourceBergen CorporationBaxter International, Inc.Beckman Coulter, Inc.Boston Scientific CorporationBristol-Myers Squibb CompanyCardinal Health, Inc.Eli Lilly & CompanyExpress Scripts, Inc.Golden Gate National Senior Care LLCHCA Inc.Health Management Associates, Inc.Johnson & JohnsonMcKesson CorporationMerck & Company, Inc.PacifiCare Health Systems, Inc.Pfizer Inc.Schering-Plough CorporationTenet Healthcare CorporationUniversal Health Care, Inc.Watson Pharmaceuticals, Inc.Wyeth8008936880089369800893898008952680089918800902068009062880091013800910168009111380091591800917408009175780092086803613728036141980361592803616308041717980656236807104108084388481251087816096558168346581683499818216698182739282164752822757394/21/2008 6:20:00 PM0100000001010304010300000103170001031702010317030104000085Press ReleaseABCABTACLBAXBECBMYBSXCAHESRXHMAJNJLLYMCKMRKPFESGPTHCWPIWYE417836_pr_frameCredit & Investment ResearchFitchResearchhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-24569201newstex/PRN-0005-24569201xml DEERFIELD, Ill., April ##, Apr. ##, #### (PR Newswire delivered by Newstex) -- DEERFIELD, Ill., April ## /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: BAX) today reported solid financial results for the first quarter of...01000000010210000400000004016000040160470401601804016001040160030401604804002000040020064/17/2008 8:06:07 AM1800000018004000180120001802000018023000180080001900000019001000PR Newswire USPRN-0005-24569201BAXTER INTERNATIONAL INCROBERT L PARKINSON JRBAXBXTRRNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-24489967newstex/BW-0001-24489967xml DEERFIELD, Ill., Apr. ##, #### (Business Wire) -- Baxter International (NYSE: BAX), will host a quarterly conference call to discuss its first quarter #### financial results on Thursday, April ##, ####, at #:## a.m. Eastern Time (#:##...040000000401600004016048040160184/14/2008 5:07:24 PM180000001800800018004000Business WireBW-0001-24489967BAXTER INTERNATIONAL INCBAXBXTRRNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-24278270newstex/BW-0001-24278270xml CHICAGO, Apr. #, #### (Business Wire) -- Baxter International, Inc. has won a long-running battle in a patent infringement suit (Fresenius USA, Inc. et al v. Baxter International Inc. et al.) against Fresenius ...020000000200200002002008020020040200200604000000040160000401603104006000040060051800000018018000Business Wire4/4/2008 8:06:12 PMBW-0001-24278270BAXTER INTERNATIONAL INCFRESENIUS MEDICAL CARE CORPBAXBXTRRFMSNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1795566ccbn/T1795566norm...-- to introduce Baxter, the speaker. I'm especially thankful for Baxter for coming this year. Obviously, a very exciting company; obviously one that at this point, we don't yet cover, but Rob Davis is here, the CFO. Mary Kay Ladone is here, the Head of Investor Relations.A lot to talk about right now as it relates to Baxter, a lot of controversy, a lot of interest. So we're really appreciative of you guys coming and we're meeting here for ## minutes and then upstairs for ## minutes. And thank you. ... 3/19/2008 4:11:00 PMBaxter International Inc.54.0000FinalBaxter International Inc. at Lehman Brothers Healthcare Conference TranscriptBAX10:45am ETTranscriptT1795566Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/fitch/376482_report_framefitch/376482_report_framepdfFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Baxter International, Inc.800910133/10/2008 6:20:00 PM0103000001031700165Credit UpdateBAX376482_report_frameCredit & Investment ResearchFitchResearchhttp://www.alacrastore.com/storecontent/fitch/408877_pr_framefitch/408877_pr_framehtmlFitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.Baxter International, Inc.800910133/4/2008 2:06:00 PM010300000103170085Press ReleaseBAX408877_pr_frameCredit & Investment ResearchFitchResearch